StonvexLoading…
StonvexStonvexStonvexCore line items from SWK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-03 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $15.13B | $15.37B | $15.78B | $16.95B |
Operating Income | $417.90M | $241.10M | $-375.70M | $37.90M |
Net Income | $401.90M | $294.30M | $-310.50M | $1.06B |
EPS (Diluted) | $2.65 | $1.95 | $-2.07 | $6.76 |
Total Assets | $21.24B | $21.85B | $23.66B | $24.96B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $280.10M | $290.50M | $449.40M | $395.60M |
Free Cash Flow OCF − CapEx | $687.90M | $753.00M | $852.60M | $-1.99B |
Shares Outstanding | 155.04M | 154.37M | 153.62M | 152.98M |